Spotlight
Obituaries
Classifieds
Families First
VCAs Best of Guide
News
Weather
Specialists
Sports
Business
Consumer
Health
Life
Out & About
Login
Recommended
Where can I find the best prices on grocery staples this week?
Recommended
Quiz: Which new NC State Fair food are you?
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WRALTechWire 30
WRALTechWire 30
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Latest News about Can/Fite
Recent news which mentions Can/Fite
Industry Analysts Seemingly Sing Praises For This Stock After Phase III Trial Results
July 14, 2022
Tickers
CANF
JNJ
MRK
PFE
Tags
Can/Fite
JNJ
Partner Content
From
Benzinga
CANF: Beginning to Flex Its Muscles; Initiating With OUTPERFORM Rating, $6.00 Price Target
February 23, 2022
Tickers
CANF
Tags
Biotech
Partner Content
CANF
From
Benzinga
Piclidenoson Takes On Otezla, a $13 Billion Psoriasis Drug
December 14, 2021
Tickers
AMGN
CANF
CELG
PFE
Tags
General
AMGN
Can/Fite
From
Benzinga
Race to Effective Psoriasis Treatment: Can-Fite's Piclidenoson May Edge Over High-Flying Amgen's Otezla. Here's Why
October 20, 2021
Tags
Health Care
Market News
Can/Fite
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.